Please login to the form below
RG3039
This page shows the latest RG3039 news and features for those working in and with pharma, biotech and healthcare.
Pfizer acquires spinal muscular atrophy research programme
Gains rights to drug candidate RG3039 in deal with Repligen that could be worth up to $70m. ... $5m. The main candidate involved in the programme is RG3039, which will undergo phase I trials carried out by Repligen in the first quarter of 2013.
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Pharma deals during January 2013
This programme includes RG3039, a small molecule drug candidate in clinical development, as well as backup compounds and enabling technologies. ... Licence. RG3039 orphan for spinal muscular atrophy. 70. Amplimmune / Daiichi Sankyo.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Senior Account Executive
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Manager
-
Competitive Salary
-
Associate Account Director
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Medical Writer
-
Competitive Salary
-
Medical Editor
-
Competitive Salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- GSK discontinues two feladilimab trials in head and neck cancer
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Roche’s Ocrevus shows significant benefit in early-stage MS patients
- Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer
- Leaders in Pharma: Samir Vattompadam
- Building Better Access to Pediatric Care Through Telehealth
- Building trust through sustainability communications
- Healthware Group acquires London-headquartered consultancy SWM
- Lucid Group promotes Clare Reynolds to Director of Business Development and Commercial Integration
- Are you ready for the digital health revolution?
PMHub
Origins Insights
Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...
Latest intelligence
- Are you ready for the digital health revolution?
- In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
- #DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
- Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
- Empowering patients empowers results
- Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Quick links
Infographics
